Related content

Ewing’s sarcoma of the kidney

By Angel Joel   Alfred Anushayanthan   Sakhuja Ankit   Sells Ryan   Zechlinski Joseph  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 314-318

Springer Publishing Company

Access to resources Recommend Favorite

Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing’s sarcoma cells

By Sonnemann Jürgen   Dreyer Linn   Hartwig Maite   Palani Chithra   Hong Le   Klier Ulrike   Bröker Barbara   Völker Uwe   Beck James  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 847-858

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients

By Luijtgaarden A.   Versleijen-Jonkers Y.   Roeffen M.   Schreuder H.   Flucke U.   Graaf W.  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 253-260

Springer Publishing Company

Access to resources Recommend Favorite

Therapy resistance mechanisms in Ewing’s sarcoma family tumors

By Ahmed Atif   Zia Hamid   Wagner Lars  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 657-663

Springer Publishing Company

Access to resources Recommend Favorite

Ewing’s Sarcoma of Mandible: A Very Rare Disease and Review of Indian Literature

By Sinha Deependra   Jha N.   Yadav Sanjay   Yadav Jitin   Sinha Rishav  

Indian Journal of Surgical Oncology, Vol. 5, Iss. 1, 2014-03 ,pp. : 81-84

Springer Publishing Company

Access to resources Recommend Favorite